French City of Paris ?100 Mil. Proposed Bond Issuance Under EMTN Program Rated 'AAA' Nov 06

  • ID: 2049453
  • November 2006
  • Region: France
  • Standard & Poors
1 of 3

PARIS (Standard & Poor's) Nov. 13, 2006--Standard & Poor's Ratings Services said today that it assigned its 'AAA' long-term senior unsecured debt rating to a proposed ?100 million bond maturing in 2014 to be issued by the French City of Paris (AAA/Stable/--) under the city's EMTN program. "The rating on the issue is the same as the issuer credit rating, which reflects the French capital's very wealthy economy, robust financial performance, and highly competent management," said Standard & Poor's credit analyst Nicolas Rivière. The rating also factors in the city's flexibility and commitment to absorbing the acceleration of its large capital investment program in the next few years, while maintaining its currently low debt burden at a level compatible with...

Companies mentioned in this report are:
- Paris (City of)

Action: New Rating

Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, insurance companies, utilities, sovereigns and structured finance programs. RatingsXpress Credit Research lets users determine the credit rating of holdings and identify key factors underlying an issuer's creditworthiness, distinguishes the different risk exposures for new and existing deals, and provides an understanding of how their analysts interpret key regulatory, political and environmental events and their economic impact.

Research type: News
This product is a is a brief one-page announcement of no more than 500 words with a quote from the analyst. It is media and investor focused with no accompanying commentary article.

Note: Product cover images may vary from those shown
2 of 3

- Paris (City of)

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown




Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer Inc.